Literature DB >> 8782165

Histochemical detection of apoptosis in Parkinson's disease.

H Mochizuki1, K Goto, H Mori, Y Mizuno.   

Abstract

Apoptosis may be an important mechanism of cell death in some experimental disease models as well as in human neurodegenerative disorders. We report evidence to indicate apoptosis in the substantia nigra of Parkinson's disease patients. We studied the midbrains of 7 patients with late onset PD, 4 patients with young onset PD and 6 control subjects using the nick-end labeling method. Intense nuclear staining indicating apoptotic process was observed in 8 out of 11 parkinsonian patients studied. Apoptosis may be a contributor to the nigral neuronal death in Parkinson's disease (PD).

Entities:  

Mesh:

Year:  1996        PMID: 8782165     DOI: 10.1016/0022-510x(95)00336-z

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  75 in total

1.  Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease.

Authors:  V Viswanath; Y Wu; R Boonplueang; S Chen; F F Stevenson; F Yantiri; L Yang; M F Beal; J K Andersen
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.

Authors:  E Ilijic; J N Guzman; D J Surmeier
Journal:  Neurobiol Dis       Date:  2011-04-16       Impact factor: 5.996

3.  Lentiviral-mediated knock-down of GD3 synthase protects against MPTP-induced motor deficits and neurodegeneration.

Authors:  Anandh Dhanushkodi; Yi Xue; Emily E Roguski; Yun Ding; Shannon G Matta; Detlef Heck; Guo-Huang Fan; Michael P McDonald
Journal:  Neurosci Lett       Date:  2018-11-01       Impact factor: 3.046

4.  Review of apoptosis vs. necrosis of substantia nigra pars compacta in Parkinson's disease.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

5.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

Authors:  S Hunot; B Brugg; D Ricard; P P Michel; M P Muriel; M Ruberg; B A Faucheux; Y Agid; E C Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

6.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 7.  Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.

Authors:  Anumantha Kanthasamy; Huajun Jin; Suneet Mehrotra; Rajakishore Mishra; Arthi Kanthasamy; Ajay Rana
Journal:  Neurotoxicology       Date:  2009-12-11       Impact factor: 4.294

8.  Nitric oxide signaling is disrupted in the yeast model for Batten disease.

Authors:  Nuno S Osório; Agostinho Carvalho; Agostinho J Almeida; Sérgio Padilla-Lopez; Cecília Leão; João Laranjinha; Paula Ludovico; David A Pearce; Fernando Rodrigues
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

9.  Targeted expression of a toxin gene to D1 dopamine receptor neurons by cre-mediated site-specific recombination.

Authors:  J Drago; P Padungchaichot; J Y Wong; A J Lawrence; J F McManus; S H Sumarsono; A L Natoli; M Lakso; N Wreford; H Westphal; I Kola; D I Finkelstein
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 10.  Programmed cell death in Parkinson's disease.

Authors:  Katerina Venderova; David S Park
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.